FDA Approves Zituvio (sitagliptin) for the Treatment of Adult Patients with Type 2 Diabetes Mellitus

AHMEDABAD, India, Oct. 20, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as ' Zydus ' ) today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news